These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26393386)

  • 21. Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease.
    Mizuno Y; Kondo T;
    Mov Disord; 2013 Jul; 28(8):1138-41. PubMed ID: 23483627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of cumulative high-frequency rTMS on freezing of gait in Parkinson's disease.
    Kim MS; Chang WH; Cho JW; Youn J; Kim YK; Kim SW; Kim YH
    Restor Neurol Neurosci; 2015; 33(4):521-30. PubMed ID: 26409410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease.
    Málly J; Farkas R; Tóthfalusi L; Stone TW
    Brain Res Bull; 2004 Sep; 64(3):259-63. PubMed ID: 15464863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
    Makkos A; Pál E; Aschermann Z; Janszky J; Balázs É; Takács K; Karádi K; Komoly S; Kovács N
    Neuropsychobiology; 2016; 73(3):169-77. PubMed ID: 27093063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial.
    Fernandez HH; Greeley DR; Zweig RM; Wojcieszek J; Mori A; Sussman NM;
    Parkinsonism Relat Disord; 2010 Jan; 16(1):16-20. PubMed ID: 19616987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-frequency rTMS over the supplementary motor area improves freezing of gait in Parkinson's disease: a randomized controlled trial.
    Mi TM; Garg S; Ba F; Liu AP; Wu T; Gao LL; Dan XJ; Chan P; McKeown MJ
    Parkinsonism Relat Disord; 2019 Nov; 68():85-90. PubMed ID: 31689588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease.
    Börnke Ch; Schulte T; Przuntek H; Müller T
    J Neural Transm Suppl; 2004; (68):61-7. PubMed ID: 15354390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan.
    Takahashi M; Fujita M; Asai N; Saki M; Mori A
    Expert Opin Pharmacother; 2018 Oct; 19(15):1635-1642. PubMed ID: 30281377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of 20 Hz versus 1 Hz Repetitive Transcranial Magnetic Stimulation on Motor Dysfunction in Parkinson's Disease: Which Is More Beneficial?
    Khedr EM; Al-Fawal B; Abdel Wraith A; Saber M; Hasan AM; Bassiony A; Nasr Eldein A; Rothwell JC
    J Parkinsons Dis; 2019; 9(2):379-387. PubMed ID: 30909248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
    Khedr EM; Mohamed KO; Ali AM; Hasan AM
    Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of istradefylline for Parkinson's disease: A systematic review and meta-analysis.
    Wang XL; Feng ST; Chen B; Hu D; Wang ZZ; Zhang Y
    Neurosci Lett; 2022 Mar; 774():136515. PubMed ID: 35149201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease.
    Okabe S; Ugawa Y; Kanazawa I;
    Mov Disord; 2003 Apr; 18(4):382-8. PubMed ID: 12671943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.
    Wagle Shukla A; Shuster JJ; Chung JW; Vaillancourt DE; Patten C; Ostrem J; Okun MS
    PM R; 2016 Apr; 8(4):356-366. PubMed ID: 26314233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study.
    Hatano T; Kano O; Sengoku R; Yoritaka A; Suzuki K; Nishikawa N; Mukai Y; Nomura K; Yoshida N; Seki M; Matsukawa MK; Terashi H; Kimura K; Tashiro J; Hirano S; Murakami H; Joki H; Uchiyama T; Shimura H; Ogaki K; Fukae J; Tsuboi Y; Takahashi K; Yamamoto T; Yanagisawa N; Nagayama H
    BMC Neurol; 2022 Mar; 22(1):71. PubMed ID: 35241003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-frequency repetitive transcranial magnetic stimulation on Parkinson motor function: a meta-analysis of randomised controlled trials.
    Zhu H; Lu Z; Jin Y; Duan X; Teng J; Duan D
    Acta Neuropsychiatr; 2015 Apr; 27(2):82-9. PubMed ID: 25592544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective pilot study of repetitive transcranial magnetic stimulation for gait dysfunction in vascular parkinsonism.
    Yip CW; Cheong PW; Green A; Prakash PK; Fook-Cheong SK; Tan EK; Lo YL
    Clin Neurol Neurosurg; 2013 Jul; 115(7):887-91. PubMed ID: 22980521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease.
    del Olmo MF; Bello O; Cudeiro J
    Clin Neurophysiol; 2007 Jan; 118(1):131-9. PubMed ID: 17097342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 study.
    Pourcher E; Fernandez HH; Stacy M; Mori A; Ballerini R; Chaikin P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):178-84. PubMed ID: 22000279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
    Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
    Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.